137 related articles for article (PubMed ID: 11001241)
1. Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.
Hirschmann S; Dannon PN; Iancu I; Dolberg OT; Zohar J; Grunhaus L
J Clin Psychopharmacol; 2000 Oct; 20(5):556-9. PubMed ID: 11001241
[TBL] [Abstract][Full Text] [Related]
2. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
3. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
Mundo E; Guglielmo E; Bellodi L
Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.
Palatnik A; Frolov K; Fux M; Benjamin J
J Clin Psychopharmacol; 2001 Jun; 21(3):335-9. PubMed ID: 11386498
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
[TBL] [Abstract][Full Text] [Related]
6. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
8. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
[TBL] [Abstract][Full Text] [Related]
9. Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study.
Shiah IS; Yatham LN; Srisurapanont M; Lam RW; Tam EM; Zis AP
J Clin Psychopharmacol; 2000 Jun; 20(3):373-8. PubMed ID: 10831027
[TBL] [Abstract][Full Text] [Related]
10. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
Dannon PN; Sasson Y; Hirschmann S; Iancu I; Grunhaus LJ; Zohar J
Eur Neuropsychopharmacol; 2000 May; 10(3):165-9. PubMed ID: 10793318
[TBL] [Abstract][Full Text] [Related]
11. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
Lepola UM; Wade AG; Leinonen EV; Koponen HJ; Frazer J; Sjödin I; Penttinen JT; Pedersen T; Lehto HJ
J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
[TBL] [Abstract][Full Text] [Related]
12. Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.
Sandmann J; Lörch B; Bandelow B; Härtter S; Winter P; Hiemke C; Benkert O
Pharmacopsychiatry; 1998 Jul; 31(4):117-21. PubMed ID: 9754844
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
[TBL] [Abstract][Full Text] [Related]
14. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
Bordet R; Thomas P; Dupuis B
Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
[TBL] [Abstract][Full Text] [Related]
15. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
[TBL] [Abstract][Full Text] [Related]
16. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer HY
J Clin Psychopharmacol; 1999 Apr; 19(2):177-82. PubMed ID: 10211920
[TBL] [Abstract][Full Text] [Related]
17. Effect of fluvoxamine on panic disorder.
Hoehn-Saric R; McLeod DR; Hipsley PA
J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
[TBL] [Abstract][Full Text] [Related]
19. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
[TBL] [Abstract][Full Text] [Related]
20. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study.
Zanardi R; Franchini L; Gasperini M; Lucca A; Smeraldi E; Perez J
J Clin Psychopharmacol; 1998 Dec; 18(6):441-6. PubMed ID: 9864075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
